THOMAS J. HERZFELD ADVISORS, INC. Alnylam Pharmaceuticals, Inc. Transaction History

THOMAS J. HERZFELD ADVISORS, INC. portfolio value:

$3,000
portfolio value

Alnylam Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 14 shares 3K $200.16 14
Q1 2016 share Decrease -100.00% -50 shares -5K $62.77 0